Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medizinisch Genetisches Zentrum (MGZ) is a Germany-based private clinical genetics practice and laboratory focused on human genetic counseling and diagnostic testing rather than therapeutic drug development. The organization provides molecular and cytogenetic testing across a broad range of inherited and prenatal indications, including multi-gene panel sequencing, clinical exome sequencing, whole exome sequencing, RNA sequencing, HLA typing, and non-invasive prenatal testing. MGZ operates an integrated model in which physician-led genetic consultation is combined with in-house laboratory analysis and interpretation. Its activities span preventive genetics, pediatric genetics, reproductive genetics, hereditary cancer genetics, and other subspecialties of medical genetics. The requested name "Center for Human Genetics and Laboratory Diagnostics" appears to refer to this active diagnostic organization, which is also represented by the MGZ brand and the abbreviation CHGLD in external databases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medizinisch Genetisches Zentrum.